Health Catalyst, Inc.·4

Jul 20, 5:19 PM ET

Nelson Steven H 4

Research Summary

AI-generated summary

Updated

Health Catalyst (HCAT) Director Steven H. Nelson Receives RSU Award

What Happened

  • Steven H. Nelson, a director of Health Catalyst, was granted 80,691 restricted stock units (RSUs) on 2026-07-16. The Form 4 reports the acquisition price as $0.00 because these RSUs are a compensatory award, not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-07-16; Form 4 filed: 2026-07-20 (timely per two-business-day rule).
  • Amount granted: 80,691 RSUs; reported acquisition price: $0.00.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Transaction code: A (award/grant).
  • Footnote: RSUs granted under the Issuer’s 2019 Stock Option and Incentive Plan. Each RSU represents a contingent right to one share. Vesting occurs on the earlier of (i) one year after grant or (ii) the date of the next Annual Meeting of stockholders.

Context

  • RSUs are a form of equity compensation; they convert to actual shares only upon vesting and typically trigger tax withholding when settled. This award reflects compensation to a director and is not the same as a purchase (which some investors view as a stronger bullish signal).